TLR4 and metabolic dysfunction-associated steatotic liver disease: In accordance with previous reports, our study shows that the blocking of the LPS-TLR4 interaction between gut pathobionts and host cells can prevent the initiation and development of NAFLD and all other obesity-related phenotypes otherwise inducible on HFD.